Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial.

Charalampia AmerikanouStavroula KanoniAndriana C KalioraAngela BaroneMladen BjelanGiuseppe D'AuriaAristea GioxariMaría José GosalbesSofia MouchtiMaria G StathopoulouBeatriz SorianoStefan StojanoskiRajarshi BanerjeeMaria HalabalakiEleni V MikropoulouAimo KanntJohn LamontCarlos LlorensFernando MarascioMiriam MarascioFrancisco J RoigIlias SmyrnioudisIraklis VarlamisSophie Visvikis-SiestMilan VukicNatasa MilicMilica Medic-StojanoskaLucia CesariniJonica CampoloFrancesco RubinoPanos DeloukasMaria Giovanna TrivellaM Pilar FrancinoGeorgios V Dedoussisnull null

Published in: Molecular nutrition & food research (2021)

Mastiha supplementation improves microbiota dysbiosis and lipid metabolite levels in patients with NAFLD, although it reduces parameters of liver inflammation/fibrosis only in severely obese patients.

Keyphrases

obese patients
bariatric surgery
gastric bypass
roux en y gastric bypass
public health
healthcare
oxidative stress
study protocol
mental health
weight loss
health information
fatty acid
health promotion
risk assessment
climate change